Joinn Laboratories China  Lt

Joinn Laboratories China Lt (6127 HK)

Health CareChina
Joinn Laboratories (China) Co., Ltd. operates as a medicines development company. The Company offers drug development, pharmaceutical analysis, pharmacologic testing, and other related services. Joinn Laboratories (China) also provides pesticide and medical device safety evaluation services.
bullishJoinn Laboratories China Lt04 Sep 2023 23:38Broker Report

Joinn Laboratories (6127 HK) – New Orders Slightly Recovered in 2Q23

1H23 bottom-line miss. Joinn reported 1H23 revenue of RMB1,012mn, up 30% YoY, and attributable net income of RMB91mn, down 76% YoY.

bearishJoinn Laboratories China Lt17 Jul 2023 17:17

Joinn Laboratories (6127.HK) - Concerns Begin to Arise when the Monkeys Become More Expensive

Joinn is the company with the strongest cyclical attribute in CXO sector, mainly because its performance growth is closely related with changes in...

bullishJoinn Laboratories China Lt17 Jul 2023 10:53Broker Report

Joinn Laboratories (6127 HK) – Core Business Maintains a Healthy Growth Momentum

Joinn released estimated preliminary results for 1H23E, expecting revenue of RMB973-1,051mn, up 25.3-35.3% YoY, and attributable net income of...

bullishJoinn Laboratories China Lt03 May 2023 07:32Broker Report

Joinn Laboratories (6127 HK) – Maintaining strong growth momentum

First quarter is usually the low season for Joinn. Net income from laboratory services, the core business of Joinn, increased by 34% YoY to RMB70mn...

bullishJoinn Laboratories China Lt04 Apr 2023 02:32Broker Report

Joinn Laboratories (6127 HK) – Taping global markets for sustainable long-term growth

Joinn reported revenue of RMB2,268mn and attributable net income of RMB1,074mn in 2022, up 50% and 93% YoY respectively.